• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗淋病的各种药物的临床疗效。

Clinical efficacy of the various drugs used in the treatment of gonorrhoeae.

作者信息

Khan Amir, Akhter Khalid

机构信息

Department of Medicine, Bacha Khan, Medical College, Mardan, Pakistan.

出版信息

J Ayub Med Coll Abbottabad. 2009 Oct-Dec;21(4):28-30.

PMID:21067018
Abstract

BACKGROUND

Gonorrhoea is a purulent inflammation of mucus membrane of the genital tract and is a highly contagious sexually transmitted disease (STD) caused by the bacterium Neisseria gonorrhoae. Both men and women can be infected through a variety of sexual contact behaviours including vaginal, anal or oral intercourses. This comparative study was carried out in New Gulail Polyclinic Jeddah, KSA from Jan 2003 to March 2004 to find the clinical efficacy of ciprofloxacin, ceftriaxone and spectinomycin, the three commonly used drugs, in the treatment of gonorrhoea.

METHODS

A total number of 300 patients suffering from gonorrhoea were included in this study. They were randomly divided into 3 groups of 100 patients each. Group-A patients were given Tablet Ciprofloxacin 500 mg, Group-B patients Injection Ceftriaxone 500 mg, and Group-C patients were put on Injection Spectinomycin 2 gm, all in stat dosage. On the 5th day following the treatment, all patients were re-examined and their clinical and laboratory findings were recorded and analysed.

RESULTS

On the 5th day following treatment the Group-A (n = 100) showed 9 (9%) partial response and 11 (11%) cases showed no response to Ciprofloxacin. In the Group-B (n = 100), 4 (4%) patients showed partial response and 6 (6%) patients showed no response to Ceftriaxone. In Group-C, out of 100 patients, 4 (4%) cases reported with partial response and 2 (2%) patients showed no response to Spectinomycin. The efficacy of these anti-microbial agents was the same in both the genders.

CONCLUSION

Anti-microbial susceptibility of N. gonorrhoeae to various antibiotics is gradually decreasing. In order to ensure full cure, all gonorrhoea patients should be followed-up after a single dosage of any antibiotic. Further research should continue for newer, effective, and preferably oral medication for the treatment of gonorrhoea.

摘要

背景

淋病是生殖道黏膜的化脓性炎症,是由淋病奈瑟菌引起的一种高度传染性的性传播疾病(STD)。男性和女性均可通过包括阴道性交、肛交或口交在内的多种性接触行为感染。本比较研究于2003年1月至2004年3月在沙特阿拉伯王国吉达的新古拉伊综合诊所进行,旨在探究环丙沙星、头孢曲松和大观霉素这三种常用药物治疗淋病的临床疗效。

方法

本研究共纳入300例淋病患者。他们被随机分为3组,每组100例。A组患者服用500毫克环丙沙星片,B组患者注射500毫克头孢曲松,C组患者注射2克大观霉素,均为单次剂量。治疗后第5天,对所有患者进行复查,并记录和分析他们的临床及实验室检查结果。

结果

治疗后第5天,A组(n = 100)有9例(9%)部分缓解,11例(11%)对环丙沙星无反应。B组(n = 100)中,4例(4%)患者部分缓解,6例(6%)患者对头孢曲松无反应。C组100例患者中,4例(4%)部分缓解,2例(2%)患者对大观霉素无反应。这些抗菌药物对两性的疗效相同。

结论

淋病奈瑟菌对各种抗生素的药敏性正在逐渐降低。为确保完全治愈,所有淋病患者在单次使用任何一种抗生素后均应进行随访。应继续开展进一步研究,寻找治疗淋病的更新、有效且最好是口服的药物。

相似文献

1
Clinical efficacy of the various drugs used in the treatment of gonorrhoeae.用于治疗淋病的各种药物的临床疗效。
J Ayub Med Coll Abbottabad. 2009 Oct-Dec;21(4):28-30.
2
National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.2005 - 2006年俄罗斯淋病奈瑟菌抗菌药物敏感性的全国监测及淋病治疗一线抗菌药物的建议
Sex Transm Infect. 2008 Aug;84(4):285-9. doi: 10.1136/sti.2007.029033. Epub 2008 Feb 6.
3
Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines.2005年至2007年巴黎淋病奈瑟菌的抗生素耐药性:对治疗指南的影响
Acta Derm Venereol. 2009;89(5):484-7. doi: 10.2340/00015555-0704.
4
[Ciprofloxacin resistance of Neisseria gonorrhoeae according to sexual habits].[根据性行为习惯分析淋病奈瑟菌对环丙沙星的耐药性]
Medicina (B Aires). 2008;68(5):358-62.
5
Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.2002年新西兰淋病奈瑟菌的抗菌药物敏感性
N Z Med J. 2004 Apr 2;117(1191):U817.
6
First case of spectinomycin resistant Neisseria gonorrhoeae isolate in New Delhi, India.印度新德里首例对壮观霉素耐药的淋病奈瑟菌分离株。
Sex Transm Infect. 2005 Apr;81(2):186-7. doi: 10.1136/sti.2004.011569.
7
Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium.单次肌内注射250毫克硫酸壮观霉素与头孢曲松钠治疗淋菌性感染的对比
Drugs Exp Clin Res. 1993;19(1):41-6.
8
Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women.头孢曲松与大观霉素治疗女性单纯性淋病的对比研究。
Am J Med. 1984 Oct 19;77(4C):68-72.
9
Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance.在一个具有高水平抗菌药物耐药性的地区,淋病的治疗和临床管理欠佳。
Int J STD AIDS. 2009 Apr;20(4):225-8. doi: 10.1258/ijsa.2008.008286.
10
Single-dose treatment of male patients with gonococcal urethritis using 2g spectinomycin: microbiological and clinical evaluations.使用2克壮观霉素对男性淋菌性尿道炎患者进行单剂量治疗:微生物学和临床评估
Int J Antimicrob Agents. 2008 Jul;32(1):50-4. doi: 10.1016/j.ijantimicag.2008.02.023. Epub 2008 Jun 6.

引用本文的文献

1
German evidence- and consensus-based guideline on the management of penile urethritis.德国基于证据和共识的阴茎尿道炎管理指南。
J Dtsch Dermatol Ges. 2025 Feb;23(2):254-275. doi: 10.1111/ddg.15617. Epub 2025 Jan 17.
2
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.耐多药淋病奈瑟菌:二十一世纪第二个十年的新威胁。
Med Microbiol Immunol. 2020 Apr;209(2):95-108. doi: 10.1007/s00430-019-00651-4. Epub 2019 Dec 4.
3
Management of Gonorrhea in Adolescents and Adults in the United States.美国青少年和成人淋病的管理
Clin Infect Dis. 2015 Dec 15;61 Suppl 8(Suppl 8):S785-801. doi: 10.1093/cid/civ731.
4
Gonorrhoea.淋病
BMJ Clin Evid. 2014 Feb 21;2014:1604.